Rezultati

eNauka >  Rezultati >  Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment
Naziv: Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment
Autori: Beljkaš, Milan  ; Petković, Miloš  ; Ružić, Dušan  ; Oljačić, Slavica  ; Nikolić, Katarina  ; Arimondo, Paola B; Srdić-Rajić, Tatjana  ; Vuletić, Ana  ; Jelić Mariokov Đurić, Ana  
Godina: 2024
Publikacija: Molecular Oncology. EACR 2024. Congress Abstracts.
ISSN: 1574-7891 Molecular Oncology Pretraži identifikator
Izdavač: John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
Tip rezultata: Konferencijski rad
Kolacija: vol. 18 br. Supplement 1 str. 238-238
URI: https://farfar.pharmacy.bg.ac.rs/handle/123456789/6347
https://enauka.gov.rs/handle/123456789/1012777
URL: https://febs.onlinelibrary.wiley.com/doi/epdf/10.1002/1878-0261.13683
https://farfar.pharmacy.bg.ac.rs/bitstream/handle/123456789/6347/Strengthening_the_epigenetic_pub_2024.pdf?sequence=1&isAllowed=y
Projekat: Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200161 (Univerzitet u Beogradu, Farmaceutski fakultet)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

Pronađi DOI


Google ScholarTM

Creative Commons licenca